Knowing the terrain and navigating it are different skills — a distinction cartographers have understood for centuries and healthcare market reformers have spent decades obscuring. Turquoise Health has built something genuinely impressive: a continuously updated, normalized, queryable index of hospital negotiated rates drawn from the machine-readable files that CMS now requires hospitals to publish. The platform’s technical achievement is real. The harder question is whether a better map changes the behavior of the parties who control the territory.
What the Data Contains
The rate data Turquoise Health ingests is structurally heterogeneous in ways that resist easy summarization. Hospitals encode their pricing files differently — some publish rates at the encounter level, others at the procedure level, and still others at the billing code level with plan-specific modifiers that require actuarial translation to make comparable. The federal price transparency requirements specify format but not granularity in ways that create wide variation in data quality across institutions. Turquoise Health’s normalization layer handles much of this variation, but the underlying problem — that American hospital pricing is a system of customized bilateral contracts rather than a posted price schedule — means that any aggregation involves tradeoffs between completeness and precision that the end user may not always see.
The business model Turquoise has built sits intelligently at the intersection of regulatory compliance and market intelligence. Health systems use the platform to understand how their published rates compare with competitors in their geography — a capability that cuts in multiple directions. A system that discovers it is underpricing relative to peers may use that intelligence to push rates up in the next contract cycle. A payer that identifies an outlier may use the data to demand renegotiation. The same dataset serves both sides of the negotiating table, and the party that uses it more strategically wins.
Pricing Power and Its Persistence
The persistence of high prices in concentrated hospital markets despite several years of public rate data suggests that transparency alone does not dissolve market power. The mechanism by which economists traditionally expect price disclosure to discipline markets assumes that buyers can substitute between sellers — that a patient facing a high price can choose a cheaper provider. Hospital care operates under a different set of constraints. Network contracts, geographic access, clinical relationships, and acute medical need interact to make meaningful substitution rare. This is not a new observation; it is simply one that the enthusiasm surrounding price transparency platforms tends to de-emphasize.
Where Turquoise Health appears to have genuine traction is in the employer-benefits market, where self-insured plan sponsors are using rate data to benchmark their own contracted rates against market norms. The KFF Employer Health Benefits Survey consistently shows that large self-insured employers are increasingly sophisticated consumers of benefits analytics, and the introduction of reliable rate benchmarking data has given their consultants and third-party administrators a sharper set of tools. Whether that sophistication translates into sustained cost pressure on providers, or whether dominant health systems simply absorb the pushback and preserve their rate floors, remains an open empirical question.
The Sociology of Transparency
There may be a more interesting sociological story in what Turquoise Health has done to the norms of healthcare contracting. For decades, the standard industry posture was that negotiated rates were proprietary secrets — competitively sensitive, contractually protected, and not for public consumption. That posture has now been legally dismantled, and while health systems continue to resist full compliance in some cases, the broad direction of travel is toward acknowledged transparency. What changes when the secrecy norm collapses is not simply the information environment; it is the rhetorical and political legitimacy of opaque contracting itself. It is harder to defend a three-hundred-percent-of-Medicare rate when the rate is published and comparable. That shift in legitimacy may prove more consequential, over time, than any individual act of rate benchmarking.
The platform is also, quietly, a research infrastructure. Academic health economists, policy researchers, and journalists have begun using Turquoise Health data to document pricing variation in ways that were previously possible only through Medicare cost reports or HCRIS data with their considerable limitations. The downstream effects of that research — its translation into policy arguments, legislative proposals, and public understanding — may turn out to matter more than the platform’s direct commercial impact. Maps, after all, have always served purposes their makers did not originally intend.
